Blog

Does the “Patent Eligibility Restoration Act of 2023” Revive Diagnostic Claims?
Blog

Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard
Blog

From SLW International: Info on the Unitary Patent and the Unified Patent Court
Blog

Chromadex v. Elysium Health – It’s Only Natural!
Blog

“Inequitable Conduct: Refresher and Update” Panel on March 16
Blog

PTO Expands the Scope of the Immunotherapy Pilot Program
Blog

Moderna to Pfizer: “The Pandemic is Over”
Blog

Tillis Bill Tries to Fix Section 101
Blog

CareDx v. Natera – The Broad Road to Patent Ineligibility
Blog

Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal
Blog

Novartis v. Accord Redux – Panel 2 Reverses Panel 1
Blog
